Levels of the soluble LDL receptor-relative LR11 decrease in overweight individuals with type 2 diabetes upon...

Area of Science:

• Endocrinology
• Metabolic Syndrome
• Cardiovascular Research

Background:

• Cardiovascular disease (CVD) is a significant complication for type 2 diabetes (T2D) patients, particularly those with obesity.
• Plasma soluble low density lipoprotein receptor-relative with 11 ligand-binding repeats (sLR11) is implicated in atherosclerosis, lipoprotein metabolism, adiposity, and vascular issues in T2D.
• Understanding sLR11's role is crucial for managing CVD risk in T2D with obesity.

Purpose of the Study:

• To investigate the impact of diet-induced weight loss on plasma sLR11 levels in overweight and obese individuals with T2D.
• To explore the relationship between changes in sLR11 levels and improvements in cardiovascular risk factors.
• To determine if weight loss directly influences sLR11 levels.

Main Methods:

• Plasma sLR11 levels were measured in 64 overweight/obese T2D patients before and after a 20-week weight loss diet.
• A control group of 64 healthy, non-obese individuals matched for age and sex was included for reference.
• Statistical analyses assessed changes in sLR11, weight, non-HDL cholesterol, and HbA1c.

Main Results:

• Baseline plasma sLR11 levels were significantly higher in T2D patients compared to controls (15.4 vs. 10.2 ng/mL).
• The 20-week diet achieved significant weight loss (9.7%) and improved CVD risk factors.
• Plasma sLR11 levels decreased significantly post-diet (to 13.3 ng/mL) and were positively associated with reductions in non-HDL cholesterol and HbA1c.

Conclusions:

• Diet-induced weight loss effectively reduces plasma sLR11 levels in overweight and obese individuals with T2D.
• The reduction in sLR11 is linked to improvements in lipid profiles and glycemic control, not directly to weight loss percentage.
• sLR11 may serve as a potential biomarker for therapeutic interventions targeting CVD risk in T2D.